A new method for detecting bowel cancer is more than 90% accurate at predicting which higher-risk people will develop the disease, according to research. About 500,000 people in the UK live with inflammatory bowel disease (IBD), including Crohn's and ulcerative colitis.

A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop the disease, research has shown. People with inflammatory bowel

Scientists say a groundbreaking new test can predict patients at high risk of developing bowel cancer with 90 per cent accuracy. The study, published in the journal Gut, could lead to blood testing for those with irritable bowel diseases like ulcerative colitis or Crohn’s who were most at risk of developing bowel cancer and help avoid some invasive procedures.

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.

A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in the five years. People with inflammatory bowel disease (IBD) — which includes conditions like ulcerative colitis and Crohn’s — are up to four times more likely to get this type of cancer,